Kulikova, Nina and Amaglobeli, Nino and Tsertsvadze, Tamar and Tsagareishvili, Paata and Sereda, Liana and Tevzadze, Mariam and Kardava, Lela and Ghirdaladze, Manana and Gachechiladze, Nino and Lukhumaidze, Mariam and Porakishvili, Nino (2009) Association between seropositivity for cytomegalovirus (CMV) and CD4+ cytotoxic T cells expansions in patients with B-cell Chronic Lymphocyte Leukaemia (B-CLL) and healthy controls. Proceedings of the Georgian Academy of Sciences, 7 (3-4). pp. 41-46. ISSN 1512-2123
Full text not available from this repository.
B cell chronic lymphocytic leukaemia (B-CLL) is characterized by the clonal expansion of CD5+CD19+CD23+ B cells. During the course of B-CLL, the expansion of neoplastic clone is accompanied by a disbalance between CD4+/CD8+ T cells and by deficiency of T cell function. We have previously shown an expansion of CD4+ perforin (PF)+ cytotoxic T cells (cytT) with undefined specificity in patients with B-CLL. It has been demonstrated by others that the expansion of CD4+PF+ T cells in control individuals is often associated with chronic viral infections. Taking into consideration that B-CLL patients are immunocompromised, with frequent viral infections, we investigated the role of CD4+PF+ cytotoxic T cells in immune responses to one of the most common chronic viral infections - human cytomegalovirus (hCMV). We studied an association of cytT cell frequencies with the chronic CMV infection in 32 B-CLL patients and 18 age-matched healthy controls. Peripheral blood mononuclear cells (PBMCs) were immunostained with anti-CD4~PerCP monoclonal antibodies (mAb), fixed, permeabilised and immunostained with anti-PF~FITC mAb. Cells were fixed and analyzed by flow cytometry. Serum samples were routinely tested for anti-IgG antibodies to CMV. Here we show that CD4+PF+ T cell expansions appeared to be strongly associated with CMV seropositivity in healthy individuals, and, particularly, in B-CLL patients. The immunocompromised status of the majority of B-CLL patients may facilitate expansion of this unusual population of cytotoxic cells to combat reactivation of a chronic CMV infection.
|Research Community:||University of Westminster > Life Sciences, School of|
|Deposited On:||25 Oct 2012 14:56|
|Last Modified:||11 Jun 2013 12:16|
Repository Staff Only: item control page